Objective Corporation (ASX:OCL) loses its 25-year Australian Department of Defence USP contract, wiping FY26 ARR growth guidance of 10 to 14%.
Charlie Youlden
Archer Materials (ASX:AXE) has signed a three-year Quantum Compute Agreement with NYSE-listed IonQ, opening a sovereign Australian quantum path.
Mithril Silver & Gold (ASX:MTH) lifts Target 1 to 75% Indicated with 464koz AuEq, sharpening the Copalquin development pathway in Mexico.
archTIS (ASX:AR9) secures a A$3.2m Australian Department of Defence renewal for Kojensi, adding A$1m ARR and A$2.2m in services work.
Echo IQ (ASX:EIQ) has raised A$110m at a tight 8.8% discount to fund US commercial expansion of its EchoSolv AI cardiac diagnostic platform.
DXN Limited (ASX:DXN) wins a A$1m ASTCA contract for a cable landing station on the Google-backed Le Vasa Pacific subsea system.
Algorae Pharmaceuticals (ASX:1AI) has won a NSW Health public hospital supply contract, validating the AlgoraeRx commercial strategy with a 3+1+1 year term.
INOVIQ (ASX:IIQ) has scrapped its 1,200-sample EXO-OC validation study after biobank quality issues, but the ovarian cancer algorithm just improved.
AdAlta (ASX:1AD) closes out its US$1m SHcell obligation as BZDS1901 CAR-T heads to Australian manufacturing and an FDA pre-IND meeting.
Swift TV (ASX:STV) has landed a follow-on 1,900-device order from Chevron, taking its installed base at Chevron accommodation sites to 3,900 devices.
